相似化合物
769-28-8 91591-59-2 109703-07-3上下游产品
CAS号22428-91-7 2-methyl-3-oxob... | CAS号107-91-5 氰乙酰胺 | CAS号110-89-4 六氢吡啶 | CAS号64-17-5 乙醇 | CAS号50421-80-2 3-Buten-2-one,4... | CAS号51727-05-0 6-二甲基-3-羧基-2-吡啶酮 | CAS号201676-71-3 2-methoxy-5,6-d... | CAS号27992-31-0 5,6-二甲基-1H-吡啶-2-酮 | CAS号65176-93-4 2-氯-3-氰基-5,6-二甲基吡啶 | CAS号113124-06-4 2-溴-5,6-二甲基-吡啶-3-甲腈 | CAS号113124-09-7 5,6-二甲基-3-氰基吡啶 | CAS号65213-96-9 2-氯-5,6-二甲基-3-硝基吡啶📜3-甲基-2,4-丁二酮置于甲醇,氨体系中,化学反应生成 2-羟基-3-氰基-5,6-二甲基吡啶
参考文献:Zur Darstellung Von α-Oxy-Und α-Aminosubstituierten Heterocyclen Synthesen Stickstoffhaltiger Heterocyclen,X. Mitteilung
标题:Zur Darstellung Von α-Oxy-Und α-Aminosubstituierten Heterocyclen Synthesen Stickstoffhaltiger Heterocyclen,X. Mitteilung
摘要:
DOI:10.1002/ardp.19552880406
专利信息
专利号:WO-2023086799-A1
优先权日:2021-11-09
标 题:Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists
发明人:HOUZE JONATHAN B; PANDYA BHAUMIK; KAPLAN ALAN P
权利人:VIGIL NEUROSCIENCE INC
摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 ('TREM2'). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.